Scholars Central

Conference abstractPublished 26 Oct 2017

Analysis of infusion phlebitis frequency in amiodarone treatment which is applied by changing the infusion site once in 12 hours

Authors: Yasemin Kalkan Ugurlu, Nuray Enc

Istanbul University, Turkey

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Amiodarone is used frequently to treat emergency patients who suffer from atrial fibrillation and ventricular tachycardia. Although intravenous amiodarone treatment has many complications, previous studies found that infusion phlebitis was the most widely observed complication. Thrombophlebitis usually occurs when high doses of amiodarone are infused over a long period in peripheral veins. Thus, to avoid this side effect, the drug shouldnÃ?¢Ã?Â?Ã?Â?t be administered in a peripheral vein for a long period. The purpose of this study is to determine the influence of infusion site change once in 12 hours in peripheral intravenous amiodarone treatment upon the occurrence of infusion phlebitis. Methodology & Theoretical Orientation: This prospective research study has been carried out with 30 patients, who are matching the criteria of participation in the study. The study has been carried out with face to face interview and with observational method. The data which were necessary to be taken from the unconscious patients were obtained from their files and relatives. Findings: It has been observed that phlebitis grew in 30% of their peripheral venous catheter, however phlebitis did not grow in 70% of them, phlebitis grew in the 7th hour in the first catheter, and it grew in the 9th hour in the second catheter. In addition, it has been determined that 22-gauge peripheral venous catheter size is significantly influential (p<0.01) in the phlebitis growth. Significance: Thrombophlebitis usually occurs when amiodarone is infused over a long period in peripheral veins. For recommendation, it can be mentioned that changing the first infusion site of the patient who started amiodarone treatment without going beyond the 7th hour after the infusion started, and changing the 2nd infusion site without going beyond the 9th hour would provide benefit in terms of preventing phlebitis growth.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nursing & Care
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Yasemin Kalkan Ugurlu”
  • BylineArticles whose byline prints “Nuray Enc”